瑞柏生物科技股份有限公司

Arthus Biosystems

Gain the tools necessary to assist in your research projects that not only may lead to important scientific discoveries in methylation and other important biochemical processes related to one-carbon metabolism, but also uncover significant clinical implications with our products.

Arthus Biosystems is the first in the world to generate high quality antibodies against S-adenosylmethionine (SAM, AdoMet, SAMe) and S-adenosylhomocysteine (SAH) that allows immunoassays to be used in the SAM, SAH and homocysteine (HCy) related research.

Our research reagents are available to scientists and students worldwide to understand the processes and behaviors of these critical metabolites under a variety of research scenarios. Our goal is to bridge the gap between important and useful research data and the potential applications in clinical diagnostic/treatment practices to benefit the public.